Yoshikawa S., Komori R., Suzuki Y., Hanabusa Y., Kusano G., Sato A., Yoshikawa S., Matsumoto T. Hypoalbuminemia, a significant risk factor for thrombocytopenia associated with tedizolid therapy, Journal of Drug Interaction Research 47, in press (2023)
Yoshikawa S., Yoshikawa S., Sato A., Kusano G., Matsumoto T. Suitability of 5% glucose solution and Solita®-T No. 3 for infusion of tedizolid phosphate, Journal of Drug Interaction Research 45, 129-133 (2021)